TABLE VII

Mean Limit of Detection of Different Biopharmaceutical Samples

MicroorganismAverage CFU/plate (Range)
WFIUnprocessed BulkFinished Bulk
Pseudomonas aeruginosa30 (21–37)20 (11–28)28 (18–36)
Staphylococcus aureus46 (34–60)38 (16–59)43 (38–56)
Clostridium sporogenes23 (12–32)31 (19–43)36 (22–56)
Aspergillus niger23 (12–32)24 (13–34)22 (17–25)
Bacillus subtilis36 (26–51)39 (36–42)36 (27–41)
Candida albicans37 (18–63)40 (22–67)26 (1–48)
Kocuria rhizophila28 (3–42)19 (11–25)18 (3–32)
Staphylococcus haemolyticus31 (17–45)18 (4–45)25 (13–37)
Penicillium spp30 (10–67)23 (4–44)20 (7–29)
Burkholderia cepacia33 (31–34)29 (28–30)29 (28–30)
Methylobacterium radiotolerans12 (9–15)12 (9–15)12 (9–15)
  • N = 9.